HOME >> MEDICINE >> NEWS
Anti-Depressant Drug Shows Promise As Weight-Loss Treatment

g during the first eight weeks appear to be losing additional weight as the treatment is continued past the six-month mark, said Gadde, although researchers have not completed analysis of these data yet. "Here we have a well-tolerated drug that has shown significant clinical benefits in reducing weight," Gadde said. "While we have to approach the results cautiously because the long-term results are not completed, we are very excited about the potential this drug has for treating obesity."

A newer-generation anti-depressant, bupropion SR is in a class by itself and has no appreciable effect on the brain chemical serotonin, as do the majority of newer anti-depressants. Bupropion SR works by increasing available amounts of norepinephrine and dopamine, two other brain chemicals implicated in the reward and pleasure pathways.

Gadde says its unique mechanism of action may account for why patients remark that bupropion does not suppress their appetite, but rather helps them feel satisfied more easily. "A lot of patients have said that, while on the drug, they can eat a small piece of pie and feel satisfied, although not necessarily full. So it appears they feel rewarded much quicker than they normally do without the drug." The only side effect commonly reported in this study was dry mouth. Burpopion SR is not approved by the FDA for weight loss and should not be used by patients with seizure disorders, anorexia or bulimia, Gadde said.

The study will continue for another 18 months. Data also are being collected on bone density and lean muscle mass. Preliminary results should be available later this summer.


'"/>

Contact: Rebecca Levine
Levin005@mc.duke.edu
919-684-4148
Duke University Medical Center
18-May-1999


Page: 1 2

Related medicine news :

1. Study Finds Psychotherapy And Anti-Depressants Equally Effective In Treating Severely Depressed Primary-Care Patients
2. Anti-Depressants: Miracle Drugs Or Placebos With A Buzz?
3. Personality, Thought To Be Stable Over Time, Changes In Healthy People Who Take A Widely Used Anti-Depressant
4. Randomized Contolled Study Shows Neostigmine Is An Effective Treatment For Acute Colonic Pseudo-Obstruction
5. Research Shows That Noncompliance Is Responsible For Half The Cases Of Nonresponse To Antihypertensive Drug Treatment
6. Anal Cancer Screening For HIV-Positive Gay And Bisexual Men Would Save Lives And Be Cost Effective, New Study Shows
7. UCSF Study Shows That An Herbal Therapy Reduces PSA Levels By Half In Men With Advanced Prostate Cancer
8. Evidence Shows Drug-Psychotherapy Combo Effective For Chronic Depression
9. Research Shows Religion Plays A Major Role In Health, Longevity
10. Balloon Procedure In The Brain? Longest Follow-Up To Date Shows Good Results
11. Study Shows Dermatologists Are Best At Removing Skin Cancers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Anti Depressant Drug Shows Promise Weight Loss Treatment

(Date:10/22/2014)... Lexington, Kentucky (PRWEB) October 22, 2014 ... an agreement that will change the current location of ... Road to South Limestone across from the University of ... be a state-of-the-art ambulatory care center, owned and operated ... meet the orthopaedic needs of children and their families ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 During the ... fresh water supply runs dangerously low, Southern Oregon’s water ... Oregon’s rivers, despite the lowest mountain snow pack on ... late summer and early autumn.* That was the observation ... the new book “Hiking Southern Oregon,” during an interview ...
(Date:10/22/2014)... there are only 24 hours in a day, that doesn’t seem ... time within their busy schedules for exercise and fitness. Fortunately, one ... get in shape. Here are five ways you can reach your ... Up Your Commute , Consider riding a bike or taking the ... daily routine. If you must use your car to get to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... and length may be showing a genetic propensity for obesity ... genes have been linked to increased body fat, but the ... lean muscle, the researchers said. At 1 year, kids ... 2 and 3, however, these genes were linked to excessive ...
(Date:10/22/2014)... By Maureen Salamon ... -- A crucial part of conventional in vitro fertilization (IVF) ... can instead take place in a device inside the vagina, ... Colombia contend that the device, called an INVOcell, might sharply ... could also make the technology more accessible to those who ...
Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
(Date:10/22/2014)... YORK , Oct. 22, 2014 Sanomedics ... August 2014 report by Global Research & Data Services, ... per year from 2014 through 2018, as demand for ... States is the world,s largest market for ... with advanced thermometers is Sanomedics International Holdings, Inc. ...
(Date:10/22/2014)... 22, 2014  AcelRx Pharmaceuticals, Inc. (NASDAQ: ... the  IAP310 study have been published in ... peer-reviewed journal with broad, multidisciplinary readership. IAP310 was ... safety and efficacy of Zalviso, also referred to ... the treatment of post-operative pain in patients following ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014  PneumRx, Inc. ... interventional pulmonology, today announced completion of enrollment in their ... RENEW Clinical Study is the FDA-approved IDE pivotal trial ... severe emphysema. It was anticipated that the ... February 2013, would take until the end of 2014 ...
Breaking Medicine Technology:Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
Cached News: